KE
Kurt M Eichler
Director

Kurt M Eichler insider trades: F-star Therapeutics (SBPH) stock buys and sales

Director, F-star Therapeutics Last trade Dec 30, 2019 34 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
12
Open-market trades
since 2009
3
Companies
last trade 2019

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Kurt reports to the SEC

Open-market buys and sales

12 trades reported on SEC Form 4, newest first

DateStockTypeValue
Dec 30, 2019SBPH↓ Sell$51K
Jun 27, 2017SBPH↑ Buy$1000K
Feb 23, 2017SBPH↑ Buy$11K
Nov 9, 2016SBPH↑ Buy$61K
Sep 19, 2016SBPH↑ Buy$25K
Sep 14, 2016SBPH↑ Buy$6K
Sep 13, 2016SBPH↑ Buy$6K
Aug 23, 2016SBPH↑ Buy$32K
Aug 4, 2016SBPH↑ Buy$10K
May 11, 2016SBPH↑ Buy$500K
Dec 31, 2010MDXG↑ Buy$50K
Oct 19, 2009MDXG.OB↑ Buy$7K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Kurt M Eichler's insider trades

Kurt M Eichler is a director at F-star Therapeutics (SBPH). Since Oct 19, 2009, Kurt has reported 11 open-market purchases worth $1.7M and 1 sale worth $51K on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (19 filings), option exercises (3 filings), other transactions (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SBPH insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.